Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 1/1998

01-01-1998 | ORIGINAL ARTICLE

2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia

Authors: E. Van Den Neste, P. Martiat, P. Mineur, A. Delannoy, C. Doyen, A. Zenebergh, J.-L. Michaux, A. Ferrant

Published in: Annals of Hematology | Issue 1/1998

Login to get access
Metadata
Title
2-Chlorodeoxyadenosine with or without daunorubicin in relapsed or refractory acute myeloid leukemia
Authors
E. Van Den Neste
P. Martiat
P. Mineur
A. Delannoy
C. Doyen
A. Zenebergh
J.-L. Michaux
A. Ferrant
Publication date
01-01-1998
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 1/1998
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s002770050355

Other articles of this Issue 1/1998

Annals of Hematology 1/1998 Go to the issue

ORIGINAL ARTICLE

Prognostic significance of retinopathy at presentation in adult acute leukemia

ORIGINAL ARTICLE

Effect of stimulation by interferonγ and tumor necrosis factorα on CD54 expression and homotypic aggregation of blasts of acute lymphoblastic leukemias

LETTER TO THE EDITOR

Red cell aplasia and megakaryocytic hypoplasia with elevated counts of CD8-positive lymphocytes after resection of a thymoma responding to cyclosporine

ORIGINAL ARTICLE

Neutrophil 5-nucleotidase reaction in chronic myelogenous leukemia, myelofibrosis with myeloid metaplasia, and polycythemia vera

ORIGINAL ARTICLE

Ex vivo evidence of lymphocyte apoptosis in hairy cell leukemia, induced by 2-chlorodeoxyadenosine treatment

CASE REPORT

Factor V inhibitor associated with cold agglutinin disease
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits